These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36036376)

  • 21. The impact of carbapenem-resistant Pseudomonas aeruginosa on clinical and economic outcomes in a Chinese tertiary care hospital: A propensity score-matched analysis.
    Chen Z; Xu Z; Wu H; Chen L; Gao S; Chen Y
    Am J Infect Control; 2019 Jun; 47(6):677-682. PubMed ID: 30554879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between Biofilm Formation and Antimicrobial Resistance in Carbapenem-Resistant
    Cho HH; Kwon KC; Kim S; Park Y; Koo SH
    Ann Clin Lab Sci; 2018 May; 48(3):363-368. PubMed ID: 29970441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro activity of fosfomycin, alone or in combination, against clinical isolates of carbapenem resistant Pseudomonas aeruginosa].
    Gómez-Garcés JL; Gil-Romero Y; Sanz-Rodríguez N; Muñoz-Paraíso C; Regodón-Domínguez M
    Enferm Infecc Microbiol Clin; 2016 Apr; 34(4):228-31. PubMed ID: 26277206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of erythromycin and fosfomycin on Pseudomonas aeruginosa biofilm in vitro].
    Xu Z; Liu F; Wang X
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):342-4. PubMed ID: 11802985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model.
    Cai Y; Fan Y; Wang R; An MM; Liang BB
    J Antimicrob Chemother; 2009 Sep; 64(3):563-6. PubMed ID: 19561148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial and antibiofilm activities of meropenem loaded-mesoporous silica nanoparticles against carbapenem-resistant
    Memar MY; Yekani M; Ghanbari H; Nabizadeh E; Vahed SZ; Dizaj SM; Sharifi S
    J Biomater Appl; 2021 Oct; 36(4):605-612. PubMed ID: 33722086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antimicrobial use and its correlations with the frequency of carbapenem-resistant Pseudomonas aeruginosa strains in a hospital setting].
    Székely E; Bucur G; Vass L; Butiurca M; Bilca D; Foldes A; Lorinczi L
    Bacteriol Virusol Parazitol Epidemiol; 2010; 55(2):179-86. PubMed ID: 21553483
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Memar MY; Adibkia K; Farajnia S; Samadi Kafil H; Khalili Y; Azargun R; Ghotaslou R
    Iran J Pharm Res; 2021; 20(2):286-296. PubMed ID: 34567162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic effect of fosfomycin and fluoroquinolones against Pseudomonas aeruginosa growing in a biofilm.
    Mikuniya T; Kato Y; Kariyama R; Monden K; Hikida M; Kumon H
    Acta Med Okayama; 2005 Oct; 59(5):209-16. PubMed ID: 16286954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
    McCaughey G; McKevitt M; Elborn JS; Tunney MM
    J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of biofilm and efflux pump in clinical isolates of carbapenem resistant P. aeruginosa.
    Li XF; Shi HQ; Liang Y; Li J; Jiang B; Song GB
    Eur Rev Med Pharmacol Sci; 2022 Mar; 26(5):1729-1737. PubMed ID: 35302222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons.
    Rojo-Bezares B; Estepa V; Cebollada R; de Toro M; Somalo S; Seral C; Castillo FJ; Torres C; Sáenz Y
    Int J Med Microbiol; 2014 May; 304(3-4):405-14. PubMed ID: 24594145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.
    Akhi MT; Khalili Y; Ghotaslou R; Yousefi S; Kafil HS; Naghili B; Sheikhalizadeh V
    Microb Drug Resist; 2018 Mar; 24(2):126-135. PubMed ID: 28654368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Carbapenem resistance in Pseudomonas aeruginosa isolated from urine cultures: prevalence and risk factors].
    Álvarez-Otero J; Lamas-Ferreiro JL; González-González L; Rodríguez-Conde I; Fernández-Soneira MJ; Arca-Blanco A; Bermúdez-Sanjurjo JR; de la Fuente-Aguado J
    Rev Esp Quimioter; 2017 Jun; 30(3):183-194. PubMed ID: 28440605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Hu YF; Liu CP; Wang NY; Shih SC
    BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Factors for Carbapenem-resistant Pseudomonas aeruginosa Infection in Children.
    Li L; Huang Y; Tang Q; Zheng Y
    Pediatr Infect Dis J; 2022 Aug; 41(8):642-647. PubMed ID: 35446814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-Dependent Synergistic Interactions of Colistin with Rifampin, Meropenem, and Tigecycline against Carbapenem-Resistant Klebsiella pneumoniae Biofilms.
    Geladari A; Simitsopoulou M; Antachopoulos C; Roilides E
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular epidemiology and carbapenem resistance of
    Khalili Y; Memar MY; Farajnia S; Adibkia K; Kafil HS; Ghotaslou R
    J Wound Care; 2021 Feb; 30(2):135-141. PubMed ID: 33573489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model.
    Lora-Tamayo J; Murillo O; Bergen PJ; Nation RL; Poudyal A; Luo X; Yu HY; Ariza J; Li J
    J Antimicrob Chemother; 2014 Sep; 69(9):2434-42. PubMed ID: 24833752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The impact of carbapenem-resistance
    Wei J; Zhu QL; Sun Z; Wang C
    Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):353-359. PubMed ID: 32370463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.